Please use a PC Browser to access Register-Tadawul
Day's Trending USA Stocks | NetClass Technology: Overnight gain 162.5%
NetClass Technology (2024 New Filing) NTCL | 0.75 | -20.78% |
Regencell Bioscience Holdings Ltd. RGC | 16.86 | -2.32% |
thredUP, Inc. Class A TDUP | 7.75 | -2.70% |
Pony AI Inc. PONY | 14.31 | +5.22% |
FARO Technologies, Inc. FARO | 43.99 | Delist |
Editor's Note: the "Trending USA Stocks" column tracks the day's top bullish stocks in the USA market, aiding investors in promptly identifying opportunities for potential gains.
06/05/2025 Eastern Time in USA The Dow Jones Industrial Average dropped by 0.95%, closing at 40829.0 points; the Nasdaq Composite dropped by 0.87%, closing at 17689.66 points; the S&P 500 Index dropped by 0.77%, closing at 5606.91 points. Sahm has compiled the Top 10 Daily Stock Price Gainers in the USA market.

NetClass Technology (2024 New Filing): Overnight gain 162.5%
NetClass Technology Co., Ltd., established in 2003, has emerged as a leading software IT service provider and smart education specialist in the education sector. The company's portfolio encompasses a wide range of offerings, including educational digital products, software development, smart classroom solutions, and cloud computing services. In recent years, NetClass has strategically pivoted towards developing comprehensive smart education solutions, with a renewed focus on leveraging mobile internet, cloud computing, and big data technologies for educational applications. The company's groundbreaking EDC Education Chain represents the first practical implementation of blockchain technology in China's education sector, with innovative projects such as the academic credit wallet garnering industry acclaim. As a recognized high-tech enterprise in Shanghai, NetClass Technology has earned widespread recognition for its industry insights and innovative capabilities. The company's commitment to advancing educational technology positions it at the forefront of the rapidly evolving EdTech landscape. With its strong track record and continued emphasis on cutting-edge solutions, NetClass Technology is well-positioned to capitalize on the growing demand for smart education technologies in China and beyond.
NetClass Technology (2024 New Filing)(NTCL) has experienced a significant surge in stock price, driven by multiple factors. As a leading provider in the smart education sector, NTCL has benefited from the ongoing digitalization of education. The company's innovative applications in emerging technologies, such as mobile internet and cloud computing, exemplified by the EDC Education Chain project, demonstrate its robust technological capabilities. NTCL's strategic partnership with Shanghai Municipal Education Commission's credit bank platform has opened new business avenues. As a Shanghai High-Tech Enterprise, NTCL's industry influence is substantial. These combined factors have propelled NTCL's stock to soar 162.5% this week, with a year-to-date gain of 464.1%, marking a remarkable performance in the market.
Regencell Bioscience Holdings Ltd.: Overnight gain 62.6%, Unique TCM approach for neurological disorders attracts investors, showing strong market potential.
Here's the content translated into professional financial news language: Regencell Bioscience Holdings Ltd., incorporated in the Cayman Islands in 2014, is a holding company specializing in the research and development of Traditional Chinese Medicine (TCM) for neurocognitive disorders and degenerative diseases. The company's primary focus is on developing treatment solutions for Attention Deficit Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD), with the aim of improving the quality of life for patients and their families. The firm is committed to establishing itself as a global market leader in ADHD and ASD therapeutics. Regencell Bioscience is driving the commercialization of related therapies through innovative bioscience research. By leveraging its expertise in TCM and modern biotechnology, the company seeks to address unmet medical needs in the neurodevelopmental disorder space. As Regencell Bioscience continues to advance its pipeline, investors are closely monitoring the company's progress in clinical trials and regulatory approvals, which could potentially unlock significant value in the rapidly growing neurocognitive disorder treatment market.
Regencell Bioscience Holdings Ltd. (RGC) has experienced a remarkable surge in stock price, driven by multiple factors. The company's unique focus on leveraging Traditional Chinese Medicine for treating neurocognitive disorders, particularly ADHD and ASD, has garnered significant investor attention. The substantial market demand for ADHD and ASD treatments, coupled with RGC's commitment to improving patients' and families' quality of life, underscores its immense market potential. As an early-stage biotech firm, RGC is perceived as a high-growth opportunity. The stock's robust performance, boasting a year-to-date increase of 2,956.7%, reflects investor confidence in the company's future prospects. This combination of innovative approach, market potential, and strong stock performance has positioned RGC as a notable player in the biotech sector.
thredUP, Inc. Class A: Overnight gain 47.8%, Strong Q1 results and raised guidance boost investor confidence in growth prospects.
ThredUp Inc. (NASDAQ: TDUP), a Delaware corporation established in January 2009, has emerged as a prominent player in the online resale market, specializing in women's and kids' apparel, footwear, and accessories. As one of the world's leading resale platforms, the company's proprietary operating system has experienced rapid growth within the retail sector, driving the expansion of the circular economy. The firm's innovative approach caters to the evolving preferences of next-generation consumers by prioritizing secondhand goods. This strategic focus has positioned ThredUp as a key player in the rapidly changing retail landscape, capitalizing on the growing demand for sustainable and cost-effective fashion alternatives. ThredUp's business model aligns with the increasing consumer interest in environmentally conscious shopping practices, potentially offering long-term growth opportunities as the resale market continues to gain traction globally. The company's commitment to reshaping consumer behavior towards secondhand purchases could have significant implications for the broader retail industry and sustainability efforts in the coming years.
ThredUP, Inc. Class A (TDUP) experienced a significant stock price surge due to multiple factors. The company's Q1 performance exceeded market expectations, with a loss per share of $0.04, outperforming the anticipated $0.07 loss. Revenue reached $71.29 million, surpassing the projected $68.19 million. Additionally, ThredUP raised its FY2025 sales guidance to $281-$291 million, above analysts' estimates of $276.42 million, demonstrating management's confidence in future growth. These positive catalysts propelled TDUP shares to a remarkable 47.8% gain, contributing to an impressive year-to-date increase of 371.9%. This robust performance reflects investors' optimism about the company's prospects in the secondhand fashion market.
The Top 10 Daily Gainers in the USA market are listed as follows:
Company&Ticker | Cap$bn | Daily Change | YTD Change |
| NetClass Technology (2024 New Filing)(NTCL.US) | 0.59 | 162.5% | 464.1% |
| Regencell Bioscience Holdings Ltd.(RGC.US) | 1.96 | 62.6% | 2956.7% |
| thredUP, Inc. Class A(TDUP.US) | 0.78 | 47.8% | 371.9% |
| Pony AI Inc.(PONY.US) | 5.09 | 47.6% | -0.2% |
| FARO Technologies, Inc.(FARO.US) | 0.81 | 34.7% | 67.0% |
| EVgo Inc Ordinary Shares - Class A(EVGO.US) | 1.12 | 32.5% | -9.4% |
| WeRide Inc. Sponsored ADR(WRD.US) | 2.57 | 31.7% | -36.4% |
| DIVERSIFIED HEALTHCARE TRUST(DHC.US) | 0.69 | 31.2% | 25.4% |
| CorMedix Inc.(CRMD.US) | 0.76 | 23.6% | 37.8% |
| Aeva Technologies, Inc. (AEVA.US) | 0.51 | 18.2% | 93.9% |
Editor's note: This content was generated by Sahm's in-house AI-enabled SaaS tool and was reviewed by our editing team.


